サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540849

バイオチップ市場レポート：製品タイプ、製造技術、分析方法、用途、エンドユーザー、地域別、2024～2032年

Biochips Market Report by Product Type, Fabrication Technique, Analysis Method, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バイオチップ市場レポート：製品タイプ、製造技術、分析方法、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオチップ市場規模は2023年に196億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに643億米ドルに達し、2024～2032年の間に13.7%の成長率（CAGR）を示すと予測しています。バイオチップの機能を強化する次世代シーケンシング技術やラボオンチップ技術の革新、遺伝子・分子研究のための政府や民間部門からの多額の資金提供、個別化医療に対する需要の高まりなどが、市場の着実な成長を後押ししています。

バイオチップ市場分析：

主要市場促進要因：バイオチップ技術の進歩とその後の技術革新が市場を大きく刺激します。さらに、感度、精度、小型化の向上もこれらのチップの需要を押し上げています。その他の市場促進要因としては、個別化医療に対する需要の高まり、ゲノミクスとプロテオミクス研究に対する投資の増大などが挙げられます。

主要市場動向：バイオチップ技術とAIとMLアルゴリズムの統合は、そのような主要動向の1つです。これは、精度を高めた精密医療、創薬、診断の開発を促進しています。これは、高度に詳細な分子解析や標的治療介入にバイオチップを採用する方向に、個別化治療や予防治療のパターンがシフトすることによって支えられます。

地理的動向：バイオチップ市場調査レポートによると、北米は医療とバイオテクノロジー研究への多額の投資によってバイオチップ市場シェアが増加しています。アジア太平洋は、中国やインドなどの国々における医療への支出増加や精密医療への注目の高まりに後押しされ、急速に成長しています。

競合情勢：市場競争は激しく、主要企業は研究開発に投資し、市場に革新的なプラットフォームを提供しています。同時に、主要参入企業は、技術的専門知識と地理的プレゼンスで優位に立つために、戦略的提携、合併、買収に乗り出しています。バイオチップ業界の主要市場参入企業には、Agilent Technologies, Inc.、bioMerieux SA、Bio-RAD Laboratories, Inc.、CapitalBio Corporation、Dynamic Biosensors GmbH、EMD Millipore Corporation、Fluidigm Corporation、Illumina, Inc.、Perkinelmer, Inc.、Thermo Fisher Scientific Inc.などがあります。

課題と機会：バイオチップ技術に関連する高コストと、特に特定の国における規制の枠組みが複雑であることが、この市場の成長に対する主要課題です。ビジネス機会は、農業、法医学、環境モニタリングなど、急速に発展しているセグメントでのバイオチップの応用拡大と、バイオチップ技術の継続的な発展に関連しています。

バイオチップ市場動向：

技術の進歩とイノベーション

バイオチップ市場は、技術の急速な進歩とバイオチップ技術の定期的な改良によって支えられています。バイオチップは、次世代シーケンシング（NGS）、ラボオンチップ、マイクロアレイ技術など、バイオチップのパワーと効果的な性能を向上させる技術へと変貌を遂げています。さらに、人工知能（AI）や機械学習（ML）アルゴリズムと統合されたバイオチップベースのソリューションの登場は、精密医療、創薬、診断関連のアプリケーションを増幅させています。バイオチップは、ゲノミクス、プロテオミクス、その他の分子生物学セグメントにおいて、より高感度、高精度、小型化へと変化し、不可欠なツールとなりつつあり、バイオチップ市場の価値を高めています。さらに、医療やバイオテクノロジーのセグメントからの新たな要求に効果的に対応できる先進的なバイオチップ製品やソリューションを発売するために、業界各社が研究開発面で継続的なイニシアチブを取っていることも、市場拡大に拍車をかけています。

個別化医療への需要の高まり

個別化医療に対する需要の高まりも、市場を大きく刺激しています。個別化医療は、遺伝的、環境的、ライフスタイル的要因による患者の個別プロファイリングに基づいて治療計画を調整する診療行為であり、バイオチップ関連技術の必要性を加速させています。加えて、医療セグメントが個別化医療や予防医療へと急速にシフトする中で、バイオチップのような高度な診断ツールに対する要求も高まっています。この動向は、効果的な管理のために詳細な分子的洞察を必要とする、がんや心血管疾患などの慢性疾患の発生率の増加によって支えられます。このように、個別化医療の範囲が拡大しているため、バイオチップは臨床や研究の現場で受け入れられ続けており、このことがさらにポジティブなバイオチップ市場の展望を生み出しています。

ゲノミクスとプロテオミクス研究への投資の増加

バイオチップの世界市場促進要因の一つは、ゲノムとプロテオーム研究への投資の増加です。すべての政府、学術機関、民間部門は、複雑な生物学的システムを理解し、革新的な健康ソリューションを考案するために、ゲノムとプロテオミクス研究に投資しています。バイオチップは、高性能解析や、遺伝学的あるいはプロテオーム学的な様々な相互作用の大規模な研究を可能にするため、大きな用途を見出しています。さらに、精密農業、法医学、環境モニタリングなど、高性能分子分析が必要とされるセグメントでの応用が拡大しています。さらに、世界の資金調達と共同研究の拡大がこの市場の範囲を広げ続け、現在進行中の新たな生命科学研究を促進するため、洗練されたバイオチッププラットフォームへの需要が高まっています。

バイオチップ市場セグメンテーション：

IMARC Groupは、世界のバイオチップ市場レポートの各セグメントにおける主要動向の分析と、2024～2032年までの世界、地域、国レベルの予測を提供しています。当レポートでは、製品タイプ、製造技術、分析方法、用途、エンドユーザーに基づいて市場を分類しています。

製品タイプ別内訳

DNAチップが最大の市場セグメントを占める

本レポートでは、製品タイプ別のバイオチップ市場の詳細な分類と分析を行っています。これにはDNAチップ、プロテインチップ、ラボオンチップ、酵素チップが含まれます。同レポートによると、DNAチップは最大セグメントです。

DNAチップはDNAマイクロアレイと呼ばれ、現在市場で最大の製品タイプです。これは、幅広い応用範囲と技術の進歩に支えられています。これらのチップは、遺伝子情報の大規模分析を容易にします。このようなチップは、ゲノミクス、診断、個別化医療の中核ツールとなります。何千もの遺伝子を同時に分析できるため、がんゲノム学、遺伝性疾患スクリーニング、薬理ゲノミクスに関連する研究に画期的な変化をもたらします。その結果、アップグレードされた技術により、より高感度で特異的、かつ効率的なDNAチップが生まれ、普及が進んでいます。バイオチップ市場レポートによると、個々のゲノミクスによる精密医療や健康治療への関心の高まりもDNAチップの需要を加速させています。市場の主要参入企業は、DNAチップの新製品を出すために広範な研究開発に従事しており、それによって医療とバイオテクノロジー企業の変化する要求に貢献しています。これとは別に、遺伝性疾患や慢性疾患の増加により、詳細な遺伝子プロファイリングが必要となるため、DNAチップは現代の診断や治療において重要な役割を担っています。したがって、DNAチップは、分子生物学と個性的な医療ソリューションの推進に不可欠なコンポーネントであるため、バイオチップ市場でより大きなシェアを占めています。

製造技術別の内訳

マイクロアレイが最大の市場セグメントを占める

製造技術別のバイオチップ市場の詳細な分類と分析も報告書に記載されています。これにはマイクロアレイとマイクロ流体が含まれます。報告書によると、マイクロアレイが最大の市場シェアを占めています。

マイクロアレイ技術は、その汎用性と様々な用途への効率性により、この市場で最も広く使用されている製造技術です。この手法では、大量の生物学的データを同時に解析することが可能であり、ゲノミクス、トランスクリプトミクス、プロテオミクス研究で使用されています。バイオチップ市場予測では、1回の実験で遺伝子やタンパク質の発現を網羅的に定量化することは、創薬、疾病診断、個別化医療にとって画期的なことであると示唆しています。新しいマイクロアレイ技術は、より正確で、より速く、よりスケールアップしたバイオチップ作製をサポートし、対応するユーザー集団の大部分で信頼性の高い検出を可能にします。マイクロアレイ技術は医療やバイオインフォマティクスのセグメントで広く利用され、研究活動を向上させるだけでなく、新しい標的療法の導入にも役立っています。さらに、最新のデータ解析技術やバイオインフォマティクス・プラットフォームとの統合により、複雑な生物学的プロセスの理解ためのマイクロアレイの利用がさらに拡大しています。個別化医療の成長に伴い、今後数年間はマイクロアレイのような高精度で高スループットの分析プラットフォームに対する需要が大幅に増加すると考えられます。したがって、マイクロアレイ技術は市場における主要な製造方法であり続け、臨床診断の改善だけでなく、生物医療研究を推進する上で基礎的な役割を果たしています。

分析方法別内訳

電気泳動が最大の市場セグメントを占める

分析手法別のバイオチップ市場の詳細な分類と分析も報告書に記載されています。これには、電気泳動、発光、質量分析、電気信号、磁気などが含まれます。同レポートによると、電気泳動が最大の市場シェアを占めています。

電気泳動は、分離技術や生体分子の分析における幅広い適用性、強さ、正確さにより、バイオチップにおける最も支配的な分析方法です。また、DNA、RNA、タンパク質をサイズと電荷に基づいて効果的に分離し、その構造と機能を明らかにすることで、機能ゲノミクス、プロテオミクス、分子生物学において重要な技術となっています。バイオチップ市場概要によると、電気泳動は、特に遺伝子マッピング、疾病診断、法医学的分析に関連するいくつかの研究所や日常的な研究所で利用されています。電気泳動は、堅牢で正確なシステムであることに加え、分子解析の分解能とスループットを向上させるために、先進のバイオチップ技術と一体となって機能することが認められています。キャピラリー電気泳動やマイクロ流体電気泳動を含む電気泳動技術は、最近、その操作をさらに強化するために革新され、より速く、より詳細な試験を提供するようになりました。個別化医療やバイオテクノロジーのセグメントで高精度の分析ツールに対するニーズが高まっていることからも明らかなように、電気泳動は今後も重要な位置を占めると考えられます。さらに、複雑化する生物学的システムと疾病メカニズムに伴い、電気泳動は市場をリードする分析手法として中心的な地位を固めています。

用途別内訳

診断が最大の市場セグメントを占める

バイオチップ市場の用途別の詳細な分類と分析も報告書に記載されています。これには、分子解析（ハイブリダイゼーション、タンパク質、免疫、生体分子、バイオマーカー、その他）、診断（遺伝子診断、腫瘍、炎症、その他）、非生物学的用途が含まれます。報告書によると、診断が最大の市場シェアを占めています。

正確で迅速かつ包括的な診断ツールが医療に必要であるため、診断は市場最大の用途です。バイオチップは、1つのチップで複数のバイオマーカーを分析でき、病気の早期かつ正確な発見に役立つという点で、診断の概念に革命をもたらしています。そのため、バイオチップの需要が高まっています。これは、がん、心血管疾患、新興ウイルス感染症などの慢性疾患や感染症の管理に重要です。これらの要因により、診断プラットフォームへのバイオチップの統合が進み、さらに試験の特異性と感度が向上し、試験結果に基づいてタイムリーで的を絞った介入を行い、患者の転帰を改善することにつながっています。これとは別に、マイクロアレイやlab-on-a-chipシステムという形でバイオチップ技術が進歩したことで、診断レベルではより簡単で、費用対効果が高く、利用しやすいものとなりました。バイオチップを利用した診断の可能性は、個別化医療の台頭によってさらに高まっています。バイオチップを利用すれば、遺伝子プロファイルの分析が可能になり、個人単位での治療が可能になるからです。精密医療と予防医療に向けた世界の医療の変化に伴い、診断目的でのバイオチップの採用はかなりの地歩を固めつつあり、これは本質的に現代の医療診断の礎石として設定され、バイオチップ市場の成長を後押ししています。

エンドユーザー別内訳

製薬企業とバイオテクノロジー企業が最大の市場セグメントを占める

本レポートでは、バイオチップ市場をエンドユーザー別に詳細に分類・分析しています。これには製薬・バイオテクノロジー企業、病院・診断センター、学術・研究機関、その他が含まれます。同レポートによると、製薬・バイオテクノロジー企業が最大の市場シェアを占めています。

バイオチップ産業における最大のエンドユーザーは製薬会社とバイオテクノロジー企業です。これは、彼らの広範な研究開発活動や、創薬・開発プロセスにおける新しく新鮮ソリューションに対する需要の増加に起因しています。バイオチップは、高性能・スクリーニング、遺伝子解析、バイオマーカー同定などのセグメントで、病気のメカニズム解明やそれに続く標的療法の開発に大いに役立っています。さらに、バイオチップ技術は、技術的に正確で、より速く、より安価な新しい方法を可能にし、医薬品開発を早め、臨床試験の計画を知らせ、促進します。この点に関して、調査対象企業がバイオチップ技術に多額の投資を行っているのは、効率を向上させ、開発コストを下げるためです。さらに、バイオチップのメーカーと製薬会社やバイオテクノロジー企業との緊密な連携は、特別な研究ニーズに合わせたバイオチップのさらなる改良を促進します。新たな治療や個別化された治療オプションに対するニーズの高まりによるプレッシャーが続く中、これらの業界ではバイオチップへの依存度が高まっており、変革する医療環境に対応するためのイノベーションと競合優位性の構築において決定的な違いを生み出す可能性があります。

地域別内訳

北米が市場をリードし、最大のバイオチップ市場シェアを占める

また、北米（米国、カナダ）、欧州（ドイツ、フランス、英国、スペイン、ロシア、イタリア、その他）、アジア太平洋（中国、インド、日本、韓国、オーストラリア、その他）、ラテンアメリカ（メキシコ、ブラジル、アルゼンチン、その他）、中東・アフリカ（トルコ、サウジアラビア、アラブ首長国連邦、その他）の主要地域市場についても包括的に分析しています。同レポートによると、バイオチップの最大地域市場は北米です。

北米地域は、質の高い医療インフラとバイオテクノロジー研究への多額の投資により、バイオチップ市場に最も貢献しています。さらに、この地域の主権は、サムスンバイオロジクスやセルトリオンといったバイオテクノロジーにおける主要な市場参入企業や、研究開発活動に対する政府の包括的な支援によっても牽引されています。これに加え、慢性疾患の増加や個別化医療の必要性が、バイオチップ技術の利用増加に拍車をかけています。米国やカナダなどの主要国では、ゲノミクスやプロテオミクスの研究助成金により、この市場の成長機会が地域的な拡大を後押ししており、これがバイオチップ市場の収益を増大させています。さらに、北米には成熟した製薬とバイオテクノロジー産業が存在するため、バイオチップアプリケーションの迅速な商業化と多様な医療環境への導入が可能です。

本レポートで扱う主要質問

  • 世界のバイオチップ市場はこれまでどのように推移してきたのか？
  • 世界のバイオチップ市場における促進要因、抑制要因、機会は何か？
  • 各駆動要因、抑制要因、機会が世界のバイオチップ市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的なバイオチップ市場はどの国か？
  • 製品タイプ別の市場内訳は？
  • バイオチップ市場で最も魅力的な製品タイプは？
  • 製造技術別の市場内訳は？
  • バイオチップ市場で最も魅力的な加工技術は？
  • 分析方法別の市場内訳は？
  • バイオチップ市場で最も魅力的な分析手法は？
  • 用途別の市場内訳は？
  • バイオチップ市場で最も魅力的な用途は？
  • エンドユーザー別の市場内訳は？
  • バイオチップ市場で最も魅力的なエンドユーザーは？
  • 市場の競合構造は？
  • 世界のバイオチップ市場における主要参入企業/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のバイオチップ市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • DNAチップ
  • プロテインチップ
  • ラボオンチップ
  • 酵素チップ

第7章 市場内訳：製造技術別

  • マイクロアレイ
  • マイクロ流体

第8章 市場内訳：分析方法別

  • 電気泳動
  • 発光
  • 質量分析
  • 電気信号
  • 磁気

第9章 市場内訳：用途別

  • 分子分析
    • 交配
    • タンパク質
    • 免疫学的
    • 生体分子
    • バイオマーカー
    • その他
  • 診断
    • 遺伝子診断
    • 腫瘍学
    • 炎症性
    • その他
  • 非生物学的使用

第10章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 病院と診断センター
  • 学術研究機関
  • その他

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • ロシア
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • 中東・アフリカ
    • トルコ
    • サウジアラビア
    • アラブ首長国連邦
    • その他

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-RAD Laboratories, Inc.
    • CapitalBio Corporation
    • Dynamic Biosensors GmbH
    • EMD Millipore Corporation
    • Fluidigm Corporation
    • Illumina, Inc.
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific, Inc.
図表

List of Figures

  • Figure 1: Global: Biochips Market: Major Drivers and Challenges
  • Figure 2: Global: Biochips Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biochips Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Biochips Market: Breakup by Fabrication Technique (in %), 2023
  • Figure 5: Global: Biochips Market: Breakup by Analysis Method (in %), 2023
  • Figure 6: Global: Biochips Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biochips Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biochips Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biochips Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Biochips (DNA Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biochips (DNA Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biochips (Protein Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biochips (Protein Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biochips (Lab-On-a-Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biochips (Lab-On-a-Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biochips (Enzyme Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biochips (Enzyme Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biochips (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biochips (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Biochips (Microfluidic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Biochips (Microfluidic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Biochips (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Biochips (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Biochips (Luminescence) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Biochips (Luminescence) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Biochips (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Biochips (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Biochips (Electrical Signals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Biochips (Electrical Signals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Biochips (Magnetism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Biochips (Magnetism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Biochips (Molecular Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Biochips (Molecular Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Biochips (Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Biochips (Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Biochips (Protein) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Biochips (Protein) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Biochips (Immunological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Biochips (Immunological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Biochips (Biomolecules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Biochips (Biomolecules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Biochips (Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Biochips (Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Biochips (Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Biochips (Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Biochips (Gene Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Biochips (Gene Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Biochips (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Biochips (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: Biochips (Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: Biochips (Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Global: Biochips (Non-Biological Usage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Global: Biochips (Non-Biological Usage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Global: Biochips (Hospitals and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Global: Biochips (Hospitals and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Global: Biochips (Academic & Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Global: Biochips (Academic & Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: North America: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: North America: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United States: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United States: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Canada: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Canada: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Europe: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Europe: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Germany: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Germany: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: France: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: France: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: United Kingdom: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: United Kingdom: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Spain: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Spain: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Russia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Russia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Italy: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Italy: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Asia Pacific: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Asia Pacific: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: China: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: China: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: India: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: India: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Japan: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Japan: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: South Korea: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: South Korea: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Australia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 99: Australia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 101: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Latin America: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 103: Latin America: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 104: Mexico: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 105: Mexico: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 106: Brazil: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 107: Brazil: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 108: Argentina: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 109: Argentina: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 110: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 111: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 112: Middle East and Africa: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 113: Middle East and Africa: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 114: Turkey: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 115: Turkey: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 116: Saudi Arabia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 117: Saudi Arabia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 118: United Arab Emirates: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 119: United Arab Emirates: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 120: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 121: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 122: Global: Biochips Industry: SWOT Analysis
  • Figure 123: Global: Biochips Industry: Value Chain Analysis
  • Figure 124: Global: Biochips Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biochips Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biochips Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biochips Market Forecast: Breakup by Fabrication Technique (in Million US$), 2024-2032
  • Table 4: Global: Biochips Market Forecast: Breakup by Analysis Method (in Million US$), 2024-2032
  • Table 5: Global: Biochips Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Biochips Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Biochips Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Biochips Market: Competitive Structure
  • Table 9: Global: Biochips Market: Key Players
目次
Product Code: SR112024A2741

The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. The market is experiencing steady growth driven by innovations in next-generation sequencing and lab-on-a-chip technologies to enhance biochip capabilities, substantial funding from governments and private sectors for genetic and molecular research, and the increasing demand for personalized medicine.

Biochips Market Analysis:

Major Market Drivers: Advances in technology and subsequent innovations in the technology of biochips greatly fuel the market. Additionally, the rise in sensitivity, accuracy, and miniaturization is also driving the demand for these chips. Other prominent drivers for the market include rising demand for personalized medicine and augmented investment in genomics and proteomics research.

Key Market Trends: The integration of biochip technology with AI and ML algorithms is one such key trend. It is facilitating the development of precision medicine, drug discovery, and diagnostics with enhanced accuracy. This can be supported by shifting personalized and preventive treatment patterns towards the adoption of biochips for highly detailed molecular analyses and targeted therapeutic interventions.

Geographical Trends: According to the biochips market research report, North America represents an increasing biochips market share driven by heavy investment in health care and biotechnology research. Asia-Pacific is rapidly growing, impelled by increasing expenditure on healthcare and a rising focus on precision medicine in countries such as China and India.

Competitive Landscape: The market is quite a competitive space where key players are investing in research and development to offer platform innovations into the market. Concurrently, the major players are entering strategic collaborations, mergers, and acquisitions to get an upper hand on technological expertise and geographical presence. Some of the major market players in the biochips industry include Agilent Technologies, Inc., bioMerieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc., among many others.

Challenges and Opportunities: The high cost associated with biochip technology, and the regulatory framework, particularly in certain countries, is complex, hence the major challenges to the growth of this market. Opportunities are related to the extension of applications of biochips in fields with fast development, such as agriculture, forensic sciences, and environmental monitoring, coupled with the continuous development of biochip technology.

Biochips Market Trends:

Technological advancements and innovations

The market is propelled by the rapid progress in technology and periodic modifications of biochip technologies. Biochips are transforming, such as the next-generation sequencing (NGS), lab-on-a-chip, and microarray technologies that improve the power and effective performance of biochips. Further, the advent of biochip-based solutions that are integrated with artificial intelligence (AI) and machine learning (ML) algorithms is amplifying precision medicine, drug discovery, and diagnostic-related applications. Biochips are becoming essential tools as they change to greater sensitivity, accuracy, and miniaturization in genomics, proteomics, and other molecular biology fields, which is enhancing biochips market value. Additionally, ongoing initiatives being taken by the prominent industry players in terms of R&D to launch advanced biochip products and solutions that could respond effectively to emerging requirements from healthcare and biotechnology verticals further fuel market expansion.

Growing demand for personalized medicine

The increasing demand for personalized medicine also significantly fuels the market. Personalized medicine as a practice based on individual profiling of patients by genetic, environmental, and lifestyle factors in tailoring treatment plans is accelerating the need for technologies related to biochips. In addition, the requirement for advanced diagnostic tools such as biochips is growing with the healthcare sector rapidly shifting towards personalized and preventive medicine. This trend can be supported by an increase in the incidence of chronic diseases such as cancer and cardiovascular disorders, which need detailed molecular insight for effective management. Thus, due to the growing scope of personalized medicine, biochips continue to get greater acceptance in clinical and research settings which is further creating a positive biochips market outlook.

Increasing investment in genomics and proteomics research

One of the key drivers for the global market of biochips is increasing investments in genome and proteome research. All governments, academic institutions, and private sectors are investing in genomic as well as proteomic studies, to understand complex biological systems and devise innovative health solutions. Biochips find large applications since they permit high-throughput analysis and large-scale studies of various interactions, such as genetically or proteomically. In addition, the growing applications in precision agriculture, forensic sciences, and environmental monitoring, among others, where high-throughput molecular analyses are required. Moreover, the demand for sophisticated biochip platforms is rising as globally growing funding and collaborative research continue to broaden the scope of this market, thus directing it to foster ongoing new life sciences research.

Biochips Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biochips market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, fabrication technique, analysis method, application, and end user.

Breakup by Product Type:

DNA Chip

Protein Chip

Lab-On-a-Chip

Enzyme Chip

DNA Chip represents the largest market segment

The report has provided a detailed breakup and analysis of the biochips market based on the product type. This includes DNA chip, protein chip, lab-on-a-chip, and enzyme chip. According to the report, DNA chip represented the largest segment.

DNA chips, otherwise called DNA microarrays, are currently the largest product type in the market. This can be supported by the wide application spectrum and technological advances. These chips facilitate large-scale analyses of genetic information; such chips become core tools in genomics, diagnostics, and personalized medicine. Thousands of genes can be analyzed simultaneously, hence making landmark changes in research related to cancer genomics, genetic disorder screening, and pharmacogenomics. It is resulting in more sensitive, specific, and efficient DNA chips with upgraded technologies, thereby increasing adoption. According to the biochips market report, the growing interest in precision medicine and health treatments by individual genomics also accelerates the demand for DNA chips. Key players in the marketplace are engaged in extensive research and development to come up with new products in DNA chips, thereby helping the changing requirements of healthcare and biotech companies. Apart from this, increasing incidences of genetic disorders and chronic diseases require detailed genetic profiling, and thus, DNA chips assume a significant role in contemporary diagnostics and therapy. DNA chips, therefore, hold a greater share in the biochips market since they represent a vital constituent in promoting molecular biology and individualistic healthcare solutions.

Breakup by Fabrication Technique:

Microarray

Microfluidic

Microarray represents the largest market segment

A detailed breakup and analysis of the biochips market based on the fabrication technique has also been provided in the report. This includes microarray and microfluidic. According to the report, microarray accounted for the largest market share.

Microarray technology is the most widely used fabrication technique in this market due to its versatility and efficiency for different applications. This method permits large amounts of biological data to be analyzed at the same time and is used in genomics, transcriptomics, and proteomic studies. The biochips market forecast suggests that quantification of gene or protein expression across the spectrum in a single experiment is game-changing for drug discovery, disease diagnosis, and personalized medicine. New microarray technologies support more accurate, faster, and scaled-up biochip fabrication to enable reliable detection over large fractions of the corresponding user population. Microarray technology is widely used in the healthcare and bioinformatics sectors to improve research activities, as well as help introduce new targeted therapies. Additionally, their integration with modern data analysis techniques and bioinformatics platforms is further expanding the use of microarrays for understanding complex biological processes. With the growth of personalized medicine, the coming years will see a great increase in demand for accurate and high-throughput analytical platforms such as microarrays. Hence, microarray technology continues to be the leading method of manufacturing in the marketplace and plays a foundational role in propelling biomedical research forward as well as improving clinical diagnostics.

Breakup by Analysis Method:

Electrophoresis

Luminescence

Mass Spectrometry

Electrical Signals

Magnetism

Electrophoresis represents the largest market segment

A detailed breakup and analysis of the biochips market based on the analysis method has also been provided in the report. This includes electrophoresis, luminescence, mass spectrometry, electrical signals, and magnetism. According to the report, electrophoresis accounted for the largest market share.

Electrophoresis is the most dominant method of analysis in biochips due to its wide applicability, strength, and precision in separation techniques, and the analysis of biological molecules. This also represents a vital technique in functional genomics, proteomics, and molecular biology through the effective separation of DNA, RNA, and proteins, based on size and charge, offering a view into their structure and function. According to the biochips market overview, electrophoresis is being utilized in several research and routine laboratories, especially in tasks related to genetic mapping, disease diagnosis, and forensic analysis. This, in addition to being a robust and accurate system, permitted working in unison with advanced biochip technologies to ensure better resolution and higher throughput of molecular analyses. Electrophoresis techniques, including capillary and microfluidic electrophoresis, have recently been innovated to further enhance its operations, moving faster and offering more detailed examinations. Evident through the increasing need for high-precision analytical tools within the fields of personalized medicine and biotechnology, electrophoresis is set to remain prominent. Moreover, it consolidates a central position as the leading analysis method in the market with the escalating complex biological systems and disease mechanisms.

Breakup by Application:

Molecular Analysis

Hybridization

Protein

Immunological

Biomolecules

Biomarker

Others

Diagnosis

Gene Diagnosis

Oncology

Inflammatory

Others

Non-Biological Usage

Diagnosis represents the largest market segment

A detailed breakup and analysis of the biochips market based on the application has also been provided in the report. This includes molecular analysis (hybridization, protein, immunological, biomolecules, biomarker, and others), diagnosis (gene diagnosis, oncology, inflammatory, and others), and non-biological usage. According to the report, diagnosis accounted for the largest market share.

Diagnosis is the largest application in the market as an accurate, fast, and comprehensive diagnostic tool is necessary in healthcare. Biochips are revolutionizing the concept of diagnosis in that they can analyze multiple biomarkers in a single chip, helping in the early and accurate detection of diseases. Therefore, this is escalating the biochips demand. This is important in managing chronic and infectious diseases, such as cancer, cardiovascular disorders, and emerging viral infections. These factors are leading to the integration of biochips in diagnostic platforms, which further resulted in enhanced specificity and sensitivity of tests, thereby leading toward better patient outcomes, based on test results, through timely and targeted interventions. Apart from this, progress in biochip technology in the form of microarrays and lab-on-a-chip systems has made things easier, cost-effective, and more accessible at the diagnostic level. The stakes for diagnostics based on biochips are further raised by the rise of personalized medicine, as these will be able to render analyses of genetic profiles to administer treatments on an individual basis. With the changing landscape of healthcare across the globe toward precision and preventive medicine, the adoption of biochips for diagnostic purposes is gaining considerable ground, which essentially sets this as a cornerstone in modern medical diagnostics and fuels the biochips market growth.

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Hospitals and Diagnostics Centers

Academic and Research Institutes

Others

Pharmaceutical and biotechnology companies represent the largest market segment

A detailed breakup and analysis of the biochips market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, hospitals and diagnostics centers, academic and research institutes, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.

The largest end users in the biochips industry are pharmaceuticals and biotechnology firms. This can be attributed to their extensive research and development activities and increased demand for new and fresh solutions in drug discovery and development processes. Biochips help these sectors immensely in areas such as high-throughput screening, gene analysis, and biomarker identification for the comprehension of the mechanisms of diseases and the subsequent development of targeted therapies. Additionally, biochip technology makes possible new technologically precise, faster, and less expensive methods that hasten drug development and inform and facilitate the planning of clinical trials, hence putting personalized medicine into action with detailed molecular insight. In regard to this, the heavy investments in biochip technology by the studied firms is to improve efficiency and lower development costs. Moreover, close collaboration between the manufacturers of biochips and pharmaceutical and biotech companies fosters further improved forms of biochips tailored to special research needs. With continued pressure from the rising need for new therapeutics and personalized treatment options, there is a growing reliance on biochips within these industries, and it can create a critical difference in innovating and building a competitive edge to deal with the transforming environment of healthcare.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Spain

Russia

Italy

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Others

Latin America

Mexico

Brazil

Argentina

Others

Middle East and Africa

Turkey

Saudi Arabia

United Arab Emirates

Others

North America leads the market, accounting for the largest biochips market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Spain, Russia, Italy, and others); Asia Pacific (China, India, Japan, South Korea, Australia, and others); Latin America (Mexico, Brazil, Argentina, and others); and the Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, and others). According to the report, North America represents the largest regional market for biochips.

The North America region is the largest contributor to the biochips market due to high-quality healthcare infrastructure and substantial investments in biotechnology research, followed by Asia-Pacific being robustly driven by technological innovation. Besides, the sovereignty of this region is also driven by some major market players in biotech, such as Samsung Biologics and Celltrion, along with comprehensive government support for R&D activities. Along with this, rising chronic diseases and personalized medicine requirements are further fueling a rise in the usage of biochip technologies. Prospective growth opportunities for this market in major countries such as the U.S. and Canada are propelling regional expansion due to genomics and proteomics research grants which are augmenting the biochips market revenue. In addition, the presence of mature pharmaceutical and biotechnology industries in North America allows expeditious commercialization and adoption of biochip applications across diverse healthcare settings.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biochips industry include:

Agilent Technologies, Inc.

bioMerieux SA

Bio-RAD Laboratories, Inc.

CapitalBio Corporation

Dynamic Biosensors GmbH

EMD Millipore Corporation

Fluidigm Corporation

Illumina, Inc.

Perkinelmer, Inc.

Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The leading biochips companies are engaged in research and development with respect to new products and technological innovations to enhance the existing technology. Major companies such as Illumina, Thermo Fisher Scientific, and Agilent Technologies execute next-generation sequencing and lab-on-chip systems. This develops sensitivity, accuracy, and throughput, hence meeting demand for precise diagnostic and research tools. Such strategic collaborations, mergers, and acquisitions often allow these firms to develop their product line and increase their geographical presence. They are also integrating the biochip technology with artificial intelligence and machine learning, which enhances the data analysis capability. These major players, therefore, meet changing requirements in personalized medicine, diagnostics, and drug discovery, hence maintaining a competitive edge and accelerating the market growth.

Biochips Market News:

September 4, 2023: Agilent and ACTRIS announced their collaboration to expedite cellular and genetic treatment in Singapore. The new partnership intends to install and operate Agilent's xCELLigence real-time cell analyzer, Seahorse XF technology, and other cell analysis portfolio in the country's largest national cell and gene therapy process development and manufacturing facility at ACTRIS.

August 17, 2023: Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the opening of a new office as well as a state-of-the-art Illumina Solutions Center (ISC) to support the growing customer base in Bengaluru.

Key Questions Answered in This Report:

  • How has the global biochips market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biochips market?
  • What is the impact of each driver, restraint, and opportunity on the global biochips market?
  • What are the key regional markets?
  • Which countries represent the most attractive biochips market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the biochips market?
  • What is the breakup of the market based on the fabrication technique?
  • Which is the most attractive fabrication technique in the biochips market?
  • What is the breakup of the market based on the analysis method?
  • Which is the most attractive analysis method in the biochips market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biochips market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biochips market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biochips market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biochips Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 DNA Chip
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Protein Chip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lab-On-a-Chip
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzyme Chip
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Fabrication Technique

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microfluidic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Analysis Method

  • 8.1 Electrophoresis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Luminescence
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Mass Spectrometry
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Electrical Signals
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Magnetism
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Molecular Analysis
    • 9.1.1 Hybridization
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Protein
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Immunological
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Biomolecules
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Biomarker
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Diagnosis
    • 9.2.1 Gene Diagnosis
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Oncology
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Inflammatory
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Others
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
  • 9.3 Non-Biological Usage
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostics Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Spain
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Russia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Italy
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 India
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 Japan
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Others
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Mexico
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Brazil
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Others
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 United Arab Emirates
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 Others
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 bioMerieux SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-RAD Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CapitalBio Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dynamic Biosensors GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 EMD Millipore Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Fluidigm Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina, Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Perkinelmer, Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific, Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis